Dean Ranasinghe
Dr Wei-Yu Lin
Dr Sarah Fordham
Dr Abrar Alharbi
Dr Nicola Sunter
et al. | Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences risk of acute myeloid leukemia | 2026 |
|
Emerita Professor Ann Daly
| HLA-B*44 Alleles and HLA-DQA1*03:01 as Genetic Risk Factors for Drug-Induced Liver Injury due to Fluoroquinolones | 2026 |
|
James Clark
Dr Simon Cockell
Emerita Professor Ann Daly
Professor Dina Tiniakos
Professor Quentin Anstee
et al. | Integrated multi-omics identifies distinct macrophage alterations during progression of metabolic dysfunction-associated steatohepatitis | 2026 |
|
Emerita Professor Ann Daly
| Usefulness of plasma bile acid profile as a prognostic biomarker for drug-induced liver injury | 2026 |
|
Emerita Professor Ann Daly
| Academia Europaea’s guidelines for the visualization of clinical outcomes | 2025 |
|
Emerita Professor Ann Daly
| Genetic and Genomic Approaches to the Study of Drug-Induced Liver Injury | 2025 |
|
Professor Quentin Anstee
Emerita Professor Ann Daly
Dr Olivier Govaere
| Insulin-like Growth Factor-1 Reflects Liver Disease Stage and Improves Prediction of Liver-related Mortality | 2025 |
|
Emerita Professor Ann Daly
| Pharmacogenomics in 2023: Big studies, big results, big implications, big responsibilities: Editorial | 2025 |
|
Emerita Professor Ann Daly
| Publisher Correction: Academia Europaea’s guidelines for the visualization of clinical outcomes (Nature Medicine, (2025), 31, 12, (3976-3980), 10.1038/s41591-025-03992-1) | 2025 |
|
Professor Fiona Oakley
Dr Simon Cockell
Dr Olivier Govaere
Emerita Professor Ann Daly
Professor Arun Sanyal
et al. | An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD) | 2024 |
|
Emerita Professor Ann Daly
Dr Olivier Govaere
Dr Simon Cockell
Professor Quentin Anstee
| Hepatic glucose production rises with the histological severity of metabolic dysfunction-associated steatohepatitis | 2024 |
|
Dr Olivier Govaere
Dr Simon Cockell
Michalina Zatorska
Kristy Wonders
Professor Dina Tiniakos
et al. | Pharmacogene expression during progression of metabolic dysfunction-associated steatotic liver disease: Studies on mRNA and protein levels and their relevance to drug treatment | 2024 |
|
Emerita Professor Ann Daly
| PharmVar GeneFocus: CYP4F2 | 2024 |
|
Emerita Professor Ann Daly
| Relevance of PNPLA3, TM6SF2, HSD17B13, and GCKR Variants to MASLD Severity in an Egyptian Population | 2024 |
|
Emerita Professor Ann Daly
| Roadmap to DILI research in Europe. A proposal from COST action ProEuroDILINet | 2024 |
|
